In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time

Emile Verhulst1, Pawel Brzeminski2, Anke de Groot1

  • 1Laboratory of Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, 2610, Belgium.

Summary

Developing new methods to measure how long cancer drug candidates bind to their targets is crucial. This study introduces a kinetic assay to better rank fibroblast activation protein alpha inhibitors for improved theranostic radioligand therapy.